Skip to content

ghall_neuroch

Active Private limited companyfounded 2023active for 2 yearsBeelbroekstraat 85, 9040 GhentKBO/BCE: BE 1002.856.670

Lifetime

2 annual accounts with figures on one time axis
peak of €309,556 in 2025
€309,556▲ 457%
peak of €210,126 in 2025
€210,126▲ 444%
peak of €261,274 in 2025
€261,274▲ 411%
€49,119▲ 65.1%
Board1 name since 2023
1 director
Documentsfilings and deeds
13-08-202613 days late
2025micro format
Gross margin from €55,552 to €309,556Result from €38,648 to €210,126Equity from €51,148 to €261,274Debts from €29,744 to €49,119Cash from €61,420 to €35,905

Key points

from the 2025 annual accounts

Result

€210,126 ▲ 444%
€38,6002024€210,0002025

The result rose in 2025 from €38,648 to €210,126.

Turnover

≈ €470,000 estimated

The micro format states no turnover.

Investments

€9,483 1.8 times depreciation
20242025

Green is investment, beige is depreciation. Machinery stands 14.9% higher than in 2024.

Liquidity

5.85 was 2.09 in 2024

Short-term debts rose from €29,744 to €49,119.

Position in the sector

€210,126

Higher net result than 89% of companies in human health. Sector median €59,520 · 21,355 companies.

2025 accounts filed 13 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as ghall_neuroch has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for ghall_neuroch. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 04-12-2023
Board & ownership

Recent changes

First establishment Beelbroekstraat 85, Ghent
Registered in the Peppol Directory Reachable for e-invoices through 0208:1002856670
Incorporation Founding capital of €12,500 · Founded by · appointed as director · published on 04-12-2023 · Gazette deed
All 7 events

Comparable companies

same main activity, similar in size and age
Company
ghall_neuroch Ghent €310,393 €309,556 84.2% -
ORTHO FARHAT Soignies €310,275 €293,888 83.4% -
Labye Gynécologie-Obstétrique Visé €312,376 €288,085 99.2% -
Glaucoma Eye Care Herent €320,255 €276,481 84.9% -
DR. VERNIERS RADIOLOOG Sint-Martens-Latem €331,381 €338,432 68.4% -
NEJAC Denderleeuw €403,148 €305,577 75.2% -
E.J. MEDICAL Ninove €406,163 €334,664 46.9% -

These companies have the same main activity as ghall_neuroch: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €310,000 and €406,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 30-11-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.362.003.1519040 Ghent, since 02-01-2024
Financial year end
31 December
Peppol
Reachable since 07-12-2023
Company details

Annual accounts 2025

€310,393▲ 284%
Filing
Filed on 13-08-2026
Financials

Insights on ghall_neuroch

ghall_neuroch has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €261,274 and a net result of €210,126.

Its solvency ranks better than 75% of 21,368 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ghall_neuroch

What is the company number of ghall_neuroch?
The company number of ghall_neuroch is 1002.856.670. The VAT number is the same number with BE in front: BE 1002.856.670.
Where is ghall_neuroch based?
The registered office is at Beelbroekstraat 85, 9040 Ghent.Company details
What does ghall_neuroch do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ghall_neuroch?
ghall_neuroch is a private limited company (BV).
When was ghall_neuroch founded?
ghall_neuroch was founded on 30-11-2023.
Is ghall_neuroch still active?
Yes, ghall_neuroch is an active enterprise in the KBO register.
What is the turnover of ghall_neuroch?
The turnover in financial year 2025 is ≈ €470,000. This figure is estimated from the gross margin of €309,556 and 31 comparable companies (NACE 86220). It probably lies between €410,000 and €650,000.Financials
Is ghall_neuroch profitable?
In financial year 2025, ghall_neuroch made a profit of €210,126.
Where can I find the annual accounts of ghall_neuroch?
ghall_neuroch filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ghall_neuroch due?
ghall_neuroch must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.